CONTENTS:
- HCV treatment initiation in the era of universal direct acting antiviral coverage - Improvements in access and persistent barriers. Jiang N., Bruneau J., Makarenko I., Minoyan N., Zang G., Hoj S.B., et al., art. 103954.
- Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya. Akiyama M.J., Riback L.R., Nyakowa M., Musyoki H., Lizcano J.A., Muller A., et al., art. 103959.
- The international regime of drug control may violate the human right to life and security. Johnstad P.G., art. 103960.
- Drug testing in Philippine schools: Historical overview and implications for drug policy. Lasco G., art. 103961.
- Who buys non-alcoholic beer in Finland? Sociodemographic characteristics and associations with regular beer purchases. Katainen A., Uusitalo L., Saarijärvi H., Erkkola M., Rahkonen O., Lintonen T., et al., art. 103962.
- From punishment to help? Continuity and change in the Norwegian decriminalization reform proposal. Kammersgaard T., art. 103963.
- Treating addiction with deep brain stimulation: Ethical and legal considerations. Lo C., Mane M., Kim J.H., Berk M., Sharp R.R., Lee K.H., et al., art. 103964.
- Pathways connecting socioeconomic marginalization and overdose: A qualitative narrative synthesis. van Draanen J., Jamula R., Karamouzian M., Mitra S., Richardson L., art. 103971.
- Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions. Price O., Man N., Sutherland R., Bruno R., Dietze P., Salom C., et al., art. 103976.